2018-2023 Global Oral Mucositis Drugs Consumption Market Report
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Oral Mucositis Drugs market for 2018-2023.
Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.
Oral Mucositis is a disorder in which an individual grows painful lesions of the mucus membranes of the mouth. It is a side effect of cancer treatment and typically increases in harshness as the dose of chemo or radiation therapy increases.
The classification of Oral Mucositis Drugs includes Mouthwash, Pain Control Medication and Other, the sales of Mouthwash are 16.9 million units, with its market share 48.8%. And the sales market share of Pain Control Medication is 38% in 2017.
Oral Mucositis Drugs is widely used to Chemotherapy Oral Mucositis and Radiotherapy Oral Mucositis. The most proportion of Oral Mucositis Drugs is to Radiotherapy Oral Mucositis, and the proportion is about 69.6% in 2017.
Over the next five years, LPI(LP Information) projects that Oral Mucositis Drugs will register a 8.0% CAGR in terms of revenue, reach US$ 640 million by 2023, from US$ 400 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Mucositis Drugs market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Mouthwash
Pain Control Medication
Other
Segmentation by application:
Chemotherapy
Radiotherapy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
3M Healthcare
GSK
Pfizer
Colgate-Palmolive
Norgine
Biovitrum
Valeant Pharmaceuticals
EUSA Pharma
Camurus
Mission Pharmacal
Clinigen Group
Midatech Pharma
Alliance Pharma
AMAG Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Oral Mucositis Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Oral Mucositis Drugs market by identifying its various subsegments.
Focuses on the key global Oral Mucositis Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oral Mucositis Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Oral Mucositis Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Oral Mucositis Drugs Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Mucositis Drugs Consumption 2013-2023
2.1.2 Oral Mucositis Drugs Consumption CAGR by Region
2.2 Oral Mucositis Drugs Segment by Type
2.2.1 Mouthwash
2.2.2 Pain Control Medication
2.2.3 Other
2.3 Oral Mucositis Drugs Consumption by Type
2.3.1 Global Oral Mucositis Drugs Consumption Market Share by Type (2013-2018)
2.3.2 Global Oral Mucositis Drugs Revenue and Market Share by Type (2013-2018)
2.3.3 Global Oral Mucositis Drugs Sale Price by Type (2013-2018)
2.4 Oral Mucositis Drugs Segment by Application
2.4.1 Chemotherapy
2.4.2 Radiotherapy
2.5 Oral Mucositis Drugs Consumption by Application
2.5.1 Global Oral Mucositis Drugs Consumption Market Share by Application (2013-2018)
2.5.2 Global Oral Mucositis Drugs Value and Market Share by Application (2013-2018)
2.5.3 Global Oral Mucositis Drugs Sale Price by Application (2013-2018)
3 Global Oral Mucositis Drugs by Players
3.1 Global Oral Mucositis Drugs Sales Market Share by Players
3.1.1 Global Oral Mucositis Drugs Sales by Players (2016-2018)
3.1.2 Global Oral Mucositis Drugs Sales Market Share by Players (2016-2018)
3.2 Global Oral Mucositis Drugs Revenue Market Share by Players
3.2.1 Global Oral Mucositis Drugs Revenue by Players (2016-2018)
3.2.2 Global Oral Mucositis Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Oral Mucositis Drugs Sale Price by Players
3.4 Global Oral Mucositis Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Oral Mucositis Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Oral Mucositis Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Oral Mucositis Drugs by Regions
4.1 Oral Mucositis Drugs by Regions
4.1.1 Global Oral Mucositis Drugs Consumption by Regions
4.1.2 Global Oral Mucositis Drugs Value by Regions
4.2 Americas Oral Mucositis Drugs Consumption Growth
4.3 APAC Oral Mucositis Drugs Consumption Growth
4.4 Europe Oral Mucositis Drugs Consumption Growth
4.5 Middle East & Africa Oral Mucositis Drugs Consumption Growth
5 Americas
5.1 Americas Oral Mucositis Drugs Consumption by Countries
5.1.1 Americas Oral Mucositis Drugs Consumption by Countries (2013-2018)
5.1.2 Americas Oral Mucositis Drugs Value by Countries (2013-2018)
5.2 Americas Oral Mucositis Drugs Consumption by Type
5.3 Americas Oral Mucositis Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Oral Mucositis Drugs Consumption by Countries
6.1.1 APAC Oral Mucositis Drugs Consumption by Countries (2013-2018)
6.1.2 APAC Oral Mucositis Drugs Value by Countries (2013-2018)
6.2 APAC Oral Mucositis Drugs Consumption by Type
6.3 APAC Oral Mucositis Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Oral Mucositis Drugs by Countries
7.1.1 Europe Oral Mucositis Drugs Consumption by Countries (2013-2018)
7.1.2 Europe Oral Mucositis Drugs Value by Countries (2013-2018)
7.2 Europe Oral Mucositis Drugs Consumption by Type
7.3 Europe Oral Mucositis Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Oral Mucositis Drugs by Countries
8.1.1 Middle East & Africa Oral Mucositis Drugs Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Oral Mucositis Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Oral Mucositis Drugs Consumption by Type
8.3 Middle East & Africa Oral Mucositis Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Oral Mucositis Drugs Distributors
10.3 Oral Mucositis Drugs Customer
11 Global Oral Mucositis Drugs Market Forecast
11.1 Global Oral Mucositis Drugs Consumption Forecast (2018-2023)
11.2 Global Oral Mucositis Drugs Forecast by Regions
11.2.1 Global Oral Mucositis Drugs Forecast by Regions (2018-2023)
11.2.2 Global Oral Mucositis Drugs Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Oral Mucositis Drugs Forecast by Type
11.8 Global Oral Mucositis Drugs Forecast by Application
12 Key Players Analysis
12.1 3M Healthcare
12.1.1 Company Details
12.1.2 Oral Mucositis Drugs Product Offered
12.1.3 3M Healthcare Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 3M Healthcare News
12.2 GSK
12.2.1 Company Details
12.2.2 Oral Mucositis Drugs Product Offered
12.2.3 GSK Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 GSK News
12.3 Pfizer
12.3.1 Company Details
12.3.2 Oral Mucositis Drugs Product Offered
12.3.3 Pfizer Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Pfizer News
12.4 Colgate-Palmolive
12.4.1 Company Details
12.4.2 Oral Mucositis Drugs Product Offered
12.4.3 Colgate-Palmolive Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Colgate-Palmolive News
12.5 Norgine
12.5.1 Company Details
12.5.2 Oral Mucositis Drugs Product Offered
12.5.3 Norgine Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Norgine News
12.6 Biovitrum
12.6.1 Company Details
12.6.2 Oral Mucositis Drugs Product Offered
12.6.3 Biovitrum Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Biovitrum News
12.7 Valeant Pharmaceuticals
12.7.1 Company Details
12.7.2 Oral Mucositis Drugs Product Offered
12.7.3 Valeant Pharmaceuticals Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Valeant Pharmaceuticals News
12.8 EUSA Pharma
12.8.1 Company Details
12.8.2 Oral Mucositis Drugs Product Offered
12.8.3 EUSA Pharma Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 EUSA Pharma News
12.9 Camurus
12.9.1 Company Details
12.9.2 Oral Mucositis Drugs Product Offered
12.9.3 Camurus Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Camurus News
12.10 Mission Pharmacal
12.10.1 Company Details
12.10.2 Oral Mucositis Drugs Product Offered
12.10.3 Mission Pharmacal Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Mission Pharmacal News
12.11 Clinigen Group
12.12 Midatech Pharma
12.13 Alliance Pharma
12.14 AMAG Pharmaceuticals
13 Research Findings and Conclusion
